Browse by Journal Title

2024

Plasmapheresis effectively abrogates severe liver toxicity of pegaspargase in a patient with acute lymphoblastic leukemia.
Tölle, M., Gökbuget, N., Habringer, S., Keller, U. and Schwartz, S.
Annals of Hematology 103 (8): 3269-3271. August 2024

2022

Conditioning with fludarabine and treosulfan compared to FLAMSA-RIC in allogeneic stem cell transplantation for myeloid malignancies: a retrospective single-center analysis.
Braitsch, K., Schwarz, A., Koch, K., Hubbuch, M., Menzel, H., Keller, U., Götze, K.S., Bassermann, F., Herhaus, P. and Verbeek, M.
Annals of Hematology 101 (6): 1311-1319. June 2022

90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years.
Rieger, K., De Filippi, R., Lindén, O., Viardot, A., Hess, G., Lerch, K., Neumeister, P., Stroux, A., Peuker, C.A., Pezzutto, A., Pinto, A., Keller, U. and Scholz, C.W.
Annals of Hematology 101 (4): 781-788. April 2022

2020

Caplacizumab: frequent local skin reactions.
Kaufeld, J., Brinkkoetter, P.T., Schreiber, A., Jabs, W.J., Bieringer, M., Bruck, H., Menne, J. and Völker, L.A.
Annals of Hematology 100 (12): 3051-3052. December 2020

First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A - results of a retrospective analysis.
Pouyiourou, M., Meyer, A., Stroux, A., Viardot, A., La Rosée, P., Maschmeyer, G., Kämpfe, D., Kahl, C., Vucinic, V., Monecke, A., Hirt, C., Weber, T., Meissner, J., Witzens-Harig, M., Böttcher, S., Schmalenberg, H., Marks, R., Prange-Krex, G., Kroschinsky, F., Hauf, E., Keller, U., Koch, K., Klapper, W., Herold, M. and Scholz, C.W.
Annals of Hematology 99 (12): 2821-2829. December 2020

Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia.
Becker, H., Pfeifer, D., Ihorst, G., Pantic, M., Wehrle, J., Rüter, B.H., Bullinger, L., Hackanson, B., Germing, U., Kuendgen, A., Platzbecker, U., Döhner, K., Ganser, A., Hagemeijer, A., Wijermans, P.W., Döhner, H., Duyster, J. and Lübbert, M.
Annals of Hematology 99 (7): 1551-1560. July 2020

2017

Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO).
Nagel, G., Weber, D., Fromm, E., Erhardt, S., Lübbert, M., Fiedler, W., Kindler, T., Krauter, J., Brossart, P., Kündgen, A., Salih, H.R., Westermann, J., Wulf, G., Hertenstein, B., Wattad, M., Götze, K., Kraemer, D., Heinicke, T., Girschikofsky, M., Derigs, H.G., Horst, H.A., Rudolph, C., Heuser, M., Göhring, G., Teleanu, V., Bullinger, L., Thol, F., Gaidzik, V.I., Paschka, P., Döhner, K., Ganser, A., Döhner, H. and Schlenk, R.F.
Annals of Hematology 96 (12): 1993-2003. 1 December 2017

Evaluating the impact of genetic and epigenetic aberrations on survival and response in acute myeloid leukemia patients receiving epigenetic therapy.
Hiller, J.K., Schmoor, C., Gaidzik, V.I., Schmidt-Salzmann, C., Yalcin, A., Abdelkarim, M., Blagitko-Dorfs, N., Döhner, K., Bullinger, L., Duyster, J., Lübbert, M. and Hackanson, B.
Annals of Hematology 96 (4): 559-565. April 2017

2016

BCR-ABL-positive acute myeloid leukemia: a new entity? Analysis of clinical and molecular features.
Neuendorff, N.R., Burmeister, T., Doerken, B. and Westermann, J.
Annals of Hematology 95 (8): 1211-1221. August 2016

2015

Flow cytometric maturity score as a novel prognostic parameter in patients with acute myeloid leukemia.
Schneider, T., Flörcken, A., Singh, A., Türkmen, S., Burmeister, T., Anagnostopoulos, I., Pezzutto, A., Dörken, B. and Westermann, J.
Annals of Hematology 94 (8): 1337-1345. August 2015

Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M(3)P).
Kortüm, K.M., Langer, C., Monge, J., Bruins, L., Zhu, Y.X., Shi, C.X., Jedlowski, P., Egan, J.B., Ojha, J., Bullinger, L., Kull, M., Ahmann, G., Rasche, L., Knop, S., Fonseca, R., Einsele, H., Stewart, A.K. and Braggio, E.
Annals of Hematology 94 (7): 1205-1211. July 2015

Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis.
Lerch, K., Meyer, A.H., Stroux, A., Hirt, C., Keller, U., Viardot, A., Marks, R., Schreiber, S., Pezzutto, A. and Scholz, C.W.
Annals of Hematology 94 (6): 981-988. June 2015

2007

Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution.
Choquet, S., Oertel, S., Leblond, V., Riess, H., Varoqueaux, N., Doerken, B. and Trappe, R.
Annals of Hematology 86 (8): 599-607. August 2007

2006

Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.
Oertel, S., Trappe, R.U., Zeidler, K., Babel, N., Reinke, P., Hummel, M., Jonas, S., Papp-Vary, M., Subklewe, M., Doerken, B., Riess, H. and Gaertner, B.
Annals of Hematology 85 : 478-484. July 2006

Successful treatment of thrombocytopenia in primary antiphospholipid antibody syndrome with the anti-CD20 antibody rituximab-monitoring of antiphospholipid and anti-GP antibodies: a case report.
Trappe, R., Loew, A., Thuss-Patience, P., Doerken, B. and Riess, H.
Annals of Hematology 85 : 134-135. February 2006

2005

Distinction of acute lymphoblastic leukemia from acute myeloid leukemia through microarray-based DNA methylation analysis.
Scholz, C., Nimmrich, I., Burger, M., Becker, E., Doerken, B., Ludwig, W.D. and Maier, S.
Annals of Hematology 84 : 236-244. 1 January 2005

2003

Recombinant human erythropoietin, epoetin beta, in patients with relapsed lymphoma treated with aggressive sequential salvage chemotherapy - results of a randomized trial.
Glossmann, J.P., Engert, A., Wassmer, G., Flechtner, H., Ko, Y., Rudolph, C., Metzner, B., Doerken, B., Wiedenmann, S., Diehl, V. and Josting, A.
Annals of Hematology 82 (8): 469-475. 1 August 2003

Preexistence and evolution of imatinib mesylate-resistant clones in chronic myelogenous leukemia detected by a PNA-based PCR clamping technique.
Kreuzer, K.A., Le Coutre, P., Landt, O., Na, I.K., Schwarz, M., Schultheis, K., Hochhaus, A. and Doerken, B.
Annals of Hematology 82 (5): 284-289. May 2003

2001

Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy.
Grenzebach, J., Schrappe, M., Ludwig, W.D., Parwaresch, R., Zimmermann, M., Gadner, H., Riehm, H. and Reiter, A.
Annals of Hematology 80 Suppl 3 : B73-B76. 1 January 2001

1999

Intracellular expression of CD61 precedes surface expression.
Kaefer, G., Willer, A., Ludwig, W.D., Kraemer, A., Hehlmann, R. and Hastka, J.
Annals of Hematology 78 : 472-474. 1 October 1999

1998

Granulocyte colony-stimulating factor shortens duration of critical neutropenia and prolongs disease-free survival after sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy for refractory and relapsed acute myeloid leukemia.
Kern, W., Aul, C., Maschmeyer, G., Kuse, R., Kerkhoff, A., Grote-Metke, A., Eimermacher, H., Kubica, U., Woermann, B., Buechner, T. and Hiddemann, W.
Annals of Hematology 77 : 115-122. 1 September 1998

Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia.
Ratei, R., Sperling, C., Karawajew, L., Schott, G., Schrappe, M., Harbott, J., Riehm, H. and Ludwig, W.D.
Annals of Hematology 77 : 107-114. 1 September 1998

Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients.
Behre, G., Link, H., Maschmeyer, G., Meyer, P., Paaz, U., Wilhelm, M. and Hiddemann, W.
Annals of Hematology 76 : 73-80. 1 February 1998

1996

New approaches in plasminogen activator therapy.
Bode, C., Gulba, D., Huber, K. and Runge, M.S.
Annals of Hematology 73 : 1-7. 1 January 1996

Hematopoietic growth factors and treatment of testicular cancer: biological interactions, routine use and dose intensive chemotherapy.
Bokemeyer, C., Kuczyk, M.A., Koehne, H., Einsele, H., Kynast, B. and Schmoll, H.J.
Annals of Hematology 72 (1): 1-9. 1 January 1996

Thrombolytic agents - an overview.
Gulba, D.C., Bode, C., Runge, M.S. and Huber, K.
Annals of Hematology 73 Suppl. 1 : S9-27. 1 January 1996

Thrombolytic therapy in acute myocardial infarction-update 1996.
Huber, K., Runge, M.S., Bode, C. and Gulba, D.C.
Annals of Hematology 73 : 29-38. 1 January 1996

Restenosis following percutaneous revascularization - the potential role of thrombin and the thrombin receptor.
Stouffer, G.A., Schmedtje, J.F., Gulba, D., Huber, K., Bode, C., Aaron, J. and Runge, M.S.
Annals of Hematology 73 Suppl. 1 : S39-S41. 1 January 1996

1995

Aerosol amphotericin b inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients.
Behre, G.F., Schwartz, S., Lenz, K., Ludwig, W.D., Schilling, E., Heinemann, V., Link, H., Boenisch, O., Treder, W., Siegert, W., Wandt, H., Trittin, A., Hiddemann, W. and Beyer, J.
Annals of Hematology 71 (6): 287-291. 1 January 1995

1994

Thrombolysis in thromobembolic disease.
Gulba, D. and Dechend, R.
Annals of Hematology 69 Suppl. : S41-S57. 1 January 1994

Interventional antimicrobial therapy in febrile neutropenic patients. Study Group of the Paul Ehrlich Society for Chemotherapy.
Link, H., Maschmeyer, G., Meyer, P., Hiddemann, W., Stille, W., Helmerking, M. and Adam, D.
Annals of Hematology 69 : 231-243. 1 January 1994

Persistence of bcr-abl mRNA-expressing cells in long-term cultures established from chronic myeloid leukemic bone marrow or blood.
Pasternak, G. and Pasternak, L.
Annals of Hematology 68 : 9-14. 1 January 1994

1993

Aggressive chemotherapy combined with G-CSF and maintenance therapy with interleukin-2 for patients with advanced myelodysplastic syndrome, subacute or secondary acute myeloid leukemia--initial results.
Ganser, A., Heil, G., Kolbe, K., Maschmeyer, G., Fischer, J.T., Bergmann, L., Mitrou, P.S., Heit, W., Heimpel, H., Huber, C. and Hoelzer, D.
Annals of Hematology 66 : 123-125. 1 January 1993

Clinical aspects of acute myeloid leukemias of the FAB types M3 and M4Eo. The AML Cooperative Group.
Haferlach, T., Gassmann, W., Loeffler, H., Juergensen, C., Noak, J., Ludwig, W.D., Thiel, E., Haase, D., Fonatsch, C., Becher, R., Schlegelberger, B., Nowrousian, M.R., Lengfelder, E., Eimermacher, H., Weh, H.J., Braumann, D., Maschmeyer, G., Koch, P., Heinecke, A., Sauerland, M.C. and Buechner, T.
Annals of Hematology 66 : 165-170. 1 January 1993